BRYTIVA

Welcome to the Brand page for “BRYTIVA”, which is offered here for Pharmaceutical, medicinal and biological preparations for the treatment and prevention of alzheimer's, brain disorders, neurological disorders, arthritis, infectious diseases, autoimmune diseases, inflammatory diseases, diabetes, cardiovascular diseases, cancers, periodontal disease, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders;.

Its status is currently believed to be active. Its class is unavailable. “BRYTIVA” is believed to be currently owned by “QUINCE THERAPEUTICS, INC.”